Swiss National Bank
VIR icon

Swiss National Bank’s Vir Biotechnology VIR Stock Holding History

Swiss National Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39M Buy
234,500
+3,000
+1% +$28.5K ﹤0.01% 1851
2026
Q1 		$2.07M Buy
231,500
+53,500
+30% +$426K ﹤0.01% 1835
2025
Q4 		$1.07M Buy
178,000
+7,800
+5% +$46.4K ﹤0.01% 2146
2025
Q3 		$972K Hold
170,200
– – ﹤0.01% 2178
2025
Q2 		$858K Sell
170,200
-4,500
-3% -$24.1K ﹤0.01% 2196
2025
Q1 		$1.13M Hold
174,700
– – ﹤0.01% 2074
2024
Q4 		$1.28M Sell
174,700
-10,500
-6% -$82.8K ﹤0.01% 2090
2024
Q3 		$1.39M Hold
185,200
– – ﹤0.01% 2063
2024
Q2 		$1.65M Hold
185,200
– – ﹤0.01% 1916
2024
Q1 		$1.88M Hold
185,200
– – ﹤0.01% 1872
2023
Q4 		$1.86M Sell
185,200
-6,300
-3% -$57.6K ﹤0.01% 1885
2023
Q3 		$1.79M Buy
191,500
+2,000
+1% +$28.5K ﹤0.01% 1905
2023
Q2 		$4.65M Buy
189,500
+31,400
+20% +$789K ﹤0.01% 1360
2023
Q1 		$3.68M Sell
158,100
-18,100
-10% -$463K ﹤0.01% 1449
2022
Q4 		$4.46M Buy
176,200
+3,600
+2% +$88.2K ﹤0.01% 1386
2022
Q3 		$3.33M Buy
172,600
+2,700
+2% +$68.6K ﹤0.01% 1530
2022
Q2 		$4.33M Buy
169,900
+15,200
+10% +$355K ﹤0.01% 1406
2022
Q1 		$3.98M Buy
154,700
+11,000
+8% +$326K ﹤0.01% 1588
2021
Q4 		$6.02M Hold
143,700
– – ﹤0.01% 1331
2021
Q3 		$6.25M Buy
143,700
+2,800
+2% +$121K ﹤0.01% 1302
2021
Q2 		$6.66M Buy
+140,900
New +$6.41M ﹤0.01% 1281

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Swiss National Bank's VIR Position: Q2 2026 in Review

Swiss National Bank increased its Vir Biotechnology (VIR) stake by 1.3% in Q2 2026, buying an estimated $28.5K and bringing the position to 234,500 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1851.

Swiss National Bank first reported a position in VIR in Q2 2021 and has held it in 21 quarters since. The position peaked at $6.66M in Q2 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Swiss National Bank held 234,500 shares of Vir Biotechnology worth $2.39M as of Q2 2026.
  • Swiss National Bank bought 3,000 Vir Biotechnology shares in Q2 2026, an estimated $28.5K.
  • Vir Biotechnology made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1851 holding.
  • Swiss National Bank first reported a position in Vir Biotechnology in Q2 2021 and has held it in 21 quarters since.
  • Swiss National Bank's Vir Biotechnology position peaked at $6.66M in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.